Siegfried Holding
Siegfried Holding AG, commonly referred to as Siegfried, is a prominent player in the pharmaceutical and chemical industry, headquartered in Switzerland (CH). Founded in 1873, the company has established a strong presence in Europe and North America, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Siegfried is renowned for its innovative solutions in contract development and manufacturing, catering to a diverse clientele in the pharmaceutical sector. The company’s commitment to quality and sustainability sets it apart, ensuring compliance with stringent regulatory standards. With a robust market position, Siegfried has achieved significant milestones, including strategic acquisitions that have expanded its capabilities and global reach. As a trusted partner in the pharmaceutical supply chain, Siegfried continues to drive advancements in drug development and production.
DitchCarbon Score
How does Siegfried Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siegfried Holding's score of 68 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Siegfried Holding's reported carbon emissions
In 2024, Siegfried Holding reported total carbon emissions of approximately 59171000 kg CO2e for Scope 1, 12622000 kg CO2e for Scope 2, and 459700000 kg CO2e for Scope 3, resulting in a combined total of about 71793000 kg CO2e for Scope 1 and 2. This reflects a slight increase in Scope 1 emissions compared to 2023, where they were about 58411000 kg CO2e, while Scope 2 emissions decreased from 14617000 kg CO2e. Siegfried Holding has set ambitious climate commitments, aiming for a 50% reduction in its Scope 1 and 2 emissions by 2030, using 2020 as the baseline year. This target is part of a broader strategy to achieve net-zero greenhouse gas emissions across its value chain by 2050. Additionally, the company plans to reduce its absolute Scope 1 and 2 emissions by 66.89% by 2033 and aims for a 90% reduction by 2050. For Scope 3 emissions, Siegfried is targeting a 32.5% reduction by 2033 from a 2022 baseline. These commitments align with industry standards and reflect Siegfried's dedication to sustainability and climate action, positioning the company as a responsible player in the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 16,300,000 | - | - | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siegfried Holding is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
